Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286051 · ClinicalTrials.gov registry record · NA
Single Injection of Ganirelix in Gonadotropin Intrauterine Insemination (IUI) Cycles
A NA study of Compare Pregnancy Rates Between FSH Stimulation and FSH and and GnRH Antagonist, sponsored by Houston Fertility Institute.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT01286051: Completed NA study of Compare Pregnancy Rates Between FSH Stimulation and FSH and and GnRH Antagonist, sponsored by Houston Fertility Institute.
NCT01286051 is a NA study of Compare Pregnancy Rates Between FSH Stimulation and FSH and and GnRH Antagonist that has completed, run by Houston Fertility Institute. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01286051, a NA study of Compare Pregnancy Rates Between FSH Stimulation and FSH and and GnRH Antagonist, has completed, sponsored by Houston Fertility Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Ovulation induction (OI) using gonadotropins is one of the most widely prescribed treatments of infertility. One common problem encountered while attempting OI using gonadotropins is premature ovulation. The purpose of this study is to examine the effect of a single injection of a medication, called ganirelix, to prevent premature ovulation. Patients will be divided into two groups. In the first group, gonadotropins will be used to stimulate the ovaries. In the second group gonadotropins will be used in addition to a single injection of ganirelix, a gonadotropin releasing hormone (GnRH) antagonist. Pregnancy rates will be compared between groups.
Primary Outcome
Follicle stimulating hormone (FSH) and IUI
Conditions Studied
Interventions
- DRUG Follistim administration
- DRUG Follistim plus Ganirelix
Study Locations (1)
Texas
- Houston Fertility Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01286051 record still lists
NCT01286051 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Compare Pregnancy Rates Between FSH Stimulation and FSH and appearing as the primary indexed condition, and to 2 interventions - of which Follistim administration is the first listed.
NCT01286051 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01286051 about?
NCT01286051 is a clinical study titled "Single Injection of Ganirelix in Gonadotropin Intrauterine Insemination (IUI) Cycles". Ovulation induction (OI) using gonadotropins is one of the most widely prescribed treatments of infertility. One common problem encountered while attempting OI using gonadotropins is premature ovulation. The purpose of this study is to examine the effect of a single injection of a medication, called...
What is the current status of trial NCT01286051?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2011-01. Estimated completion is 2012-09.
What conditions does trial NCT01286051 study?
This clinical trial studies the following conditions: Compare Pregnancy Rates Between FSH Stimulation and FSH and, GnRH Antagonist.
What interventions are being tested in trial NCT01286051?
The interventions under investigation include: Follistim administration (DRUG), Follistim plus Ganirelix (DRUG).
Who is sponsoring clinical trial NCT01286051?
This trial is sponsored by Houston Fertility Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01286051 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01286051's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia